Journals / Turkish Journal of Surgery / 2022 / Cilt: 38 - Sayı: 1

The role of bioimpedance spectroscopy method in severity and stages of breast cancer-related lymphedema

Meme kanserine bağlı lenfödem şiddeti ve evrelerinde biyoimpedans spektroskopi yönteminin rolü

Pages
11–17
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We found a significant correlation between BCRL stages and BIS, and it appears that BIS is an appropriate, inexpensive, simple, and noninvasive technique for detecting the stages of BCRL.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The correlation between lymphedema severity and stages determined by standard diagnostic methods and Bioimpedance Spectroscopy (BIS) technique was examined in breast cancer-related lymphedema (BCRL) patients.
📊
Key Findings & Data:Material and Methods: The bioimpedance analyzer device was connected to the 1.0 cm disc electrodes which were connected to the affected and unaffected (healthy) arm of the patients.
💡
Conclusion & Impact:We found a significant correlation between BCRL stages and BIS, and it appears that BIS is an appropriate, inexpensive, simple, and noninvasive technique for detecting the stages of BCRL.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The correlation between lymphedema severity and stages determined by standard diagnostic methods and Bioimpedance Spectroscopy (BIS) technique was examined in breast cancer-related lymphedema (BCRL) patients. Material and Methods: The bioimpedance analyzer device was connected to the 1.0 cm disc electrodes which were connected to the affected and unaffected (healthy) arm of the patients. We evaluated the performance of the impedance (Z) at multiple frequencies (5-50-100-200 kHz) and phase angle (PA), resistance (R), and reactance (XC) at 50 kHz on the lymphedema severity and stages. Bioimpedance measurements were applied to all volunteers in cooperation with the Physical Therapy and Rehabilitation Department. In this study, the correlation between BCRL severity and stages and bioimpedance values was examined. Results: A total of 31 female patients were recruited to compare the BIS technique with standard diagnostic techniques. The severity of lymphedema was found among the patients as follows; mild 14 (45.2%), moderate 10 (32.3%), and severe 7 (22.6%). The stage distribution of volunteers was; 15 (48.4%) patients in Stage 0, 10 (32.3%) patients in Stage 1, 5 (16.1%) patients in Stage 2, and 1 (3.2%) patient in Stage 3. The ratio of affected and unaffected arm bioimpedance mean values were calculated. Although, this ratio at 50-100-200 kHz Z and 50kHz R were significantly correlated with the lymphedema stages (p 0.05). Conclusion: The BIS technique is timesaving and can determine lymphedema stages. We found a significant correlation between BCRL stages and BIS, and it appears that BIS is an appropriate, inexpensive, simple, and noninvasive technique for detecting the stages of BCRL.

Özet

Giriş ve Amaç: Meme kanserine bağlı lenfödem (BCRL) hastalarında lenfödem şiddeti ile standart tanı yöntemleri ve Biyoimpedans Spektroskopisi (BIS) tekniği ile belirlenen evreler arasındaki korelasyon incelendi. Gereç ve Yöntem: Biyoimpedans analiz cihazı, hastaların etkilenen ve etkilenmeyen (sağlıklı) koluna bağlanan 1.0 cm’lik disk elektrotlara bağlandı. Çoklu frekanslarda (5-50-100-200 kHz) ve faz açısında (PA), dirençte (R) ve 50 kHz’de reaktansta (XC) empedansın (Z) performansını lenfödem şiddeti ve evreleri üzerinde değerlendirdik. Fizik Tedavi ve Rehabilitasyon Bölümü ile iş birliği içinde tüm gönüllülere biyoempedans ölçümleri yapıldı. Bu çalışmada BCRL şiddeti ile evreleri ve biyoempedans değerleri arasındaki ilişki incelenmiştir. Bulgular: BIS tekniğini standart tanı teknikleri ile karşılaştırmak için toplam 31 kadın çalışmaya alındı. Hastalar arasında lenfödem şiddeti şu şekilde bulundu; hafif 14 (%45.2), orta 10 (%32.3) ve şiddetli 7 (%22,6). Gönüllülerin etap dağılımı ise; Evre 0’da 15 (%48,4) hasta, Evre 1’de 10 (%32,3), Evre 2’de 5 (%16,1) hasta ve Evre 3’te 1 (%3,2) hasta etkilenen ve etkilenmeyen kol biyoempedans ortalaması oran değerleri hesaplandı. 50-100-200 kHz Z ve 50kHz R’de bu oran lenfödem evreleri ile anlamlı olarak korele olmasına rağmen (p 0,05) . Sonuç: BIS tekniği zamandan tasarruf sağlar ve lenfödem evrelerini belirleyebilir. BCRL evreleri ile BIS arasında anlamlı bir korelasyon bulduk ve BIS›nin BCRL evrelerini saptamak için uygun, ucuz, basit ve invaziv olmayan bir teknik olduğu görülüyor.

🔖

Cite This Article

TURGAY, T., DENKÇEKEN, T., MARALCAN, G. (2022). The role of bioimpedance spectroscopy method in severity and stages of breast cancer-related lymphedema. Turkish Journal of Surgery, Cilt: 38 - Sayı: 1, 11–17. https://ajindex.com/articles/614243

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 2021; 71(3): 209-49.
  2. Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg 2018; 7(4): 379-403. https://doi. org/10.21037/gs.2017.11.04 3. Nguyen TT, Hoskin TL, Habermann EB, Cheville AL, Boughey JC. Breast cancer-related lymphedema risk is related to multidisciplinary treatment and not surgery alone: results from a large cohort study. Ann Surg Oncol 2017; 24(10): 2972-80. https://doi.org/10.1245/s10434- 017-5960-x 4. He L, Qu H, Wu Q, Song Y. Lymphedema in survivors of breast cancer. Oncol Lett 2020; 19(3): 2085-96.
  3. Smoot BJ, Wong JF, Dodd MJ. Comparison of diagnostic accuracy of clinical measures of breast cancer-related lymphedema: area under the curve. Arch Phys Med Rehabil 2011; 92(4): 603-10. https://doi. org/10.1016/j.apmr.2010.11.017 6. Qin ES, Bowen MJ, Chen WF. Diagnostic accuracy of bioimpedance spectroscopy in patients with lymphedema: a retrospective cohort analysis. J Plast Reconstr Aesthet Surg 2018; 71(7): 1041-50. https:// doi.org/10.1016/j.bjps.2018.02.012 7. Seward C, Skolny M, Brunelle C, Asdourian M, Salama L, Taghian AG. A comprehensive review of bioimpedance spectroscopy as a diagnostic tool for the detection and measurement of breast cancer-related lymphedema. J Surg Oncol 2016; 114(5): 537-42.
  4. Czerniec SA, Ward LC, Refshauge KM, Beith J, Lee MJ, York S, et al. Assessment of breast cancer-related arm lymphedema--comparison of physical measurement methods and self-report. Cancer Invest 2010; 28(1): 54-62.
  5. Executive Committee of the International Society of L. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology 2020; 53(1): 3-19.
  6. Krishnan GH, Nanda A, Natarajan RA. Synovial fluid density measurement for diagnosis of arthritis. Biomed Pharmacol J 2014; 7(1): 221-4.
  7. Baumgartner RN, Chumlea WC, Roche AF. Bioelectric impedance phase angle and body composition. Am J Clin Nutr 1988; 48(1): 16-23. https://doi.org